Timothy J Fischer

USPTO Granted Patents = 40 (Patent Applications = 2)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 3.5

ph-index = 15

Forward Citations = 680(Granted Patents)

Location History:

Plantation, FL (US) (1991 - 1998)
Oro Valley, AZ (US) (2003 - 2006)
Raleigh, NC (US) (1994 - 2020)

Company Filing History:

13 out of 46

Tripath Imaging, Inc.

Coulter Electronics, Inc.

Coulter International Corp.

patents

8. 1 out of 514

Ventana Medical Systems, Inc.

patents

Years Active: 1991-2020

Loading Chart...

40 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10527526 - Methods and compositions for preparing samples for immunostaining (2020-01-07),

2. 8476033 - Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer (2013-07-02),

3. 8372591 - MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease (2013-02-12),

4. 8252904 - Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer (2012-08-28),

5. 8076093 - Monoclonal antibodies and methods for their use in the detection of cervical disease (2011-12-13),

6. 8058404 - MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease (2011-11-15),

7. 7899623 - Methods and computer program products for analysis and optimization of marker candidates for cancer prognosis (2011-03-01),

8. 7846692 - HE4 monoclonal antibodies and methods for their use (2010-12-07),

9. 7632498 - MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease (2009-12-15),

10. 7595380 - Monoclonal antibodies and methods for their use in the detection of cervical disease (2009-09-29),

11. 7510838 - Methods and compositions for the detection of cervical disease (2009-03-31),

12. 7455973 - Methods and compositions for the detection of cervical disease (2008-11-25),

13. 7300748 - Method for enhancing staining of microorganisms (2007-11-27),

14. 7211438 - Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample (2007-05-01),

15. 7179612 - Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality (2007-02-20),

Title: Innovator Spotlight: Timothy J Fischer - Pioneering Advances in Immunostaining and Ovarian Cancer Detection

Introduction:

Timothy J Fischer, a prolific inventor based in Raleigh, NC (US), has made significant contributions to the fields of immunostaining and cancer detection through his innovative patents and research endeavors.

Latest Patents:

Fischer's latest patents showcase his expertise in developing cutting-edge methods and compositions for preparing samples for immunostaining. One notable patent involves the use of surfactants and chaotropic agents to enhance sample preparation for immunological staining without the need for extreme heat, thus preserving the cellular morphology of the sample. Another groundbreaking patent focuses on the development of monoclonal antibodies for diagnosing ovarian cancer and identifying patients at higher risk. These antibodies specifically target glycodelin, a protein associated with ovarian cancer.

Career Highlights:

During his illustrious career, Fischer has worked with reputable companies such as Tripath Imaging, Inc. and Coulter Corporation, where he honed his skills and expertise in the field of biotechnology. His innovative approach to research and development has led to the successful commercialization of several groundbreaking technologies.

Collaborations:

Fischer has had the privilege of collaborating with esteemed professionals in the industry, including Adriann J Taylor and Douglas P Malinowski. Together, they have worked on various projects aimed at advancing the field of biomedical research and improving diagnostic techniques for diseases like ovarian cancer.

Conclusion:

In conclusion, Timothy J Fischer's outstanding contributions to the fields of immunostaining and cancer detection have established him as a trailblazer in the biotechnology industry. His dedication to innovation and his collaborative spirit continue to drive advancements in medical research, benefitting patients and healthcare professionals worldwide.

This text is generated by artificial intelligence and may not be accurate.